project id: TCGA-BLCA; case submitter id: TCGA-DK-AA6R; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; concentration: 0.16; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.57; rna integrity number: 8.2; age at index: 68; days to birth: -25196; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1933; age at diagnosis: 25196; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 5041.0; icd 10 code: C67.2; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lateral wall of bladder; synchronous malignancy: Not Reported; tissue or organ of origin: Lateral wall of bladder; tumor grade: Not Reported; year of diagnosis: 2001; alcohol history: Not Reported; cigarettes per day: 3.0136986301369864; pack years smoked: 55.0; is ffpe: false; composition: Not Reported; days to collection: 4591; initial weight: 340.0; sample id: 82bc393c-5391-497a-a0dc-41c077ae9c40; sample submitter id: TCGA-DK-AA6R-01A; portion id: b6a1bebd-2995-4780-b8d3-5e13907d520d; portion submitter id: TCGA-DK-AA6R-01A-11; slide id: 260432ab-829e-4040-8109-18471bb0202c; slide submitter id: TCGA-DK-AA6R-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0; section location: TOP;